Ejandra, Fabian L.

HRN: 28-82-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/18/2025
10/07/2025
IV
600mg
Q8H
Nonhealing Wound, Left Foot
Waiting Final Action 
09/18/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/18/2025
09/25/2025
IV
1.5g
Q 6H
Nonhealing Wound, Left Foot
Waiting Final Action 
09/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/23/2025
10/04/2025
IV
2.25g
Q6h
Infected Wound
Checking Initial Appropriateness 
10/02/2025
MUPIROCIN 2%, 15G (TUBE)
10/02/2025
10/09/2025
TOPICAL
15g
BID
Sacral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: